FindTrial
Sign In

The Effectiveness of Different Treatments for Patients with Thoracic Endometriosis Syndrome(TES)

The Effectiveness of Different Treatments for Patients with Thoracic Endometriosis Syndrome(TES)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400083182
Enrollment
Unknown
Registered
2024-04-17
Start date
2024-04-18
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thoracic endometriosis syndrome

Interventions

Standardized long term management group:standardized long term medication and/ or surgery
Follow up group without any medical intervention:none
Retrospective group:none

Sponsors

Obstetrics and Gynaecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 55 Years

Inclusion criteria

Inclusion criteria: Patients who were diagnosed with "thoracic endometriosis syndrome", "pulmonary endometriosis", "diaphragmatic endometriosis" pathologically/ radiologically/ clinically; and/or patients complaint "periodic/ catamenial hemoptysis" or "periodic/ catamenial pneumothorax"

Exclusion criteria

Exclusion criteria: Periodic hemoptysis or pneumothorax proven to be caused by other reasons; Pathologically confirmed no evidence of endometriosis;Participating in other clinical studies

Design outcomes

Primary

MeasureTime frame
TES related symptoms (e.g. hemoptysis, pneumothorax) complete remission rate;—

Secondary

MeasureTime frame
improvement rate of quality of life;partly remission rate in 2 years;progression rate;recurrent rate in 2 years;—

Countries

China

Contacts

Public ContactYi Xiaofang

Obstetrics and Gynaecology Hospital of Fudan University

yix@fudan.edu.cn+86 150 2658 5241

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026